ReviewTherapeutic advances in drug safety2018
Strategies to promote public engagement around deprescribing.
Review in Therapeutic advances in drug safety, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 32 citations in OpenAlex.
- Integrating patient education on deprescribing into care delivery: Learnings from the Optimize pragmatic trial.Patient education and counseling · 2026Trial
- How Are Deprescribing Clinical Practice Guidelines Disseminated and Implemented? A Cross-Sectional Study of International Organisational Stakeholders.Basic & clinical pharmacology & toxicology · 2026Article
- Editorial: Optimizing medication management in older adults: addressing polypharmacy, deprescribing and represcribing challenges.Frontiers in medicine · 2026Article
- Exploring the Barriers and Facilitators of Deprescribing in Older Adults: Qualitative Study of Patients and Geriatrics Experts.Journal of Korean medical science · 2025Article
- The development of a Community Service Announcement to raise awareness of the Home Medicines Review health service program.Australasian journal on ageing · 2025Article
- Proceedings of the Canadian Medication Appropriateness and Deprescribing Network's 2023 National Meeting.Drug safety · 2024Article
- Strategies to guide the successful implementation of deprescribing in community practice: Lessons learned from the front line.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC · 2024Article
- Knowledge, attitudes and beliefs toward polypharmacy among older people attending Family Medicine Clinic, Nairobi, Kenya.BMC geriatrics · 2024Article
- Practical Incorporation of Stakeholder-Informed Ethics into Research Funding Decisions.Progress in community health partnerships : research, education, and action · 2024Article
- Optimizing clinical outcomes in polypharmacy through poly-de-prescribing: a longitudinal study.Frontiers in medicine · 2024Article
- Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper.European geriatric medicine · 2023Article
- A Proposed Curricular Framework for an Interprofessional Approach to Deprescribing.Medical science educator · 2023Article
- TANGO: Development of Consumer Information Leaflets to Support TAperiNG of Opioids in Older Adults with Low Back Pain and Hip and Knee Osteoarthritis.Drugs & aging · 2023Article
- Challenges and Successes of Global Deprescribing Networks: A Qualitative Key Informant Study.Journal of gerontological nursing · 2022Article
- Foreword to the first special collection: Addressing the invisible iatrogenic epidemic: the role of deprescribing in polypharmacy and inappropriate medication use.Therapeutic advances in drug safety · 2019Article
- How to change workflow to enhance implementation of professional services in community pharmacies: A deprescribing case study.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPCArticle
- Deprescribing practices in Canada: A scoping review.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPCArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
Abstract
Many seniors remain unaware that certain medications may be harmful, despite high rates of polypharmacy and inappropriate medication use among community-dwelling older adults. Patient education is an effective method for reducing the use of inappropriate medications. Increasing public awareness and engagement is essential for promoting shared decision-making to deprescribe. The Canadian Deprescribing Network was created to address the lack of a systematic pan-Canadian initiative to implement deprescribing among older Canadians. The Canadian Deprescribing Network deliberately included patient advocates in its organization from the outset, in order to ensure a key strategic focus on public awareness and education. In this paper, we present the processes and activities rolled out by the Canadian Deprescribing Network as a blueprint model for engaging the public on deprescribing. Embedded within the structure of the network, the subcommittee on public awareness and engagement implements an action plan that includes needs assessments, population surveys, focus groups, deprescribing fairs, national stakeholders' meetings, public lectures and monthly exchanges with community champions and seniors' organizations. Educational materials and online media have been developed based on the answers to the questions: what information do seniors need about deprescribing? who should this information be delivered to? who needs to deliver the message? and how should seniors be engaged in deprescribing? In conjunction with seniors' organizations, members of the Network have iteratively refined key deprescribing messages, disseminated information about deprescribing, engaged the press and created a grass roots-driven public awareness and education campaign across Canada. Over 3000 seniors and seniors' organizations are involved, with over 25,000 educational tools being distributed across the country.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.